- Home
- RDHL vs DSS Comparison
RDHL vs DSS Comparison
Compare RDHL & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- DSS
- Stock Information
- Founded
- RDHL 2009
- DSS 1984
- Country
- RDHL Israel
- DSS United States
- Employees
- RDHL N/A
- DSS N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- RDHL Health Care
- DSS Consumer Discretionary
- Exchange
- RDHL Nasdaq
- DSS Nasdaq
- Market Cap
- RDHL 6.8M
- DSS 7.3M
- IPO Year
- RDHL N/A
- DSS N/A
- Fundamental
- Price
- RDHL $2.45
- DSS $0.93
- Analyst Decision
- RDHL
- DSS
- Analyst Count
- RDHL 0
- DSS 0
- Target Price
- RDHL N/A
- DSS N/A
- AVG Volume (30 Days)
- RDHL 121.9K
- DSS 83.2K
- Earning Date
- RDHL 04-11-2025
- DSS 03-31-2025
- Dividend Yield
- RDHL N/A
- DSS N/A
- EPS Growth
- RDHL N/A
- DSS N/A
- EPS
- RDHL N/A
- DSS N/A
- Revenue
- RDHL $3,707,000.00
- DSS $19,097,000.00
- Revenue This Year
- RDHL $224.90
- DSS N/A
- Revenue Next Year
- RDHL $82.69
- DSS N/A
- P/E Ratio
- RDHL N/A
- DSS N/A
- Revenue Growth
- RDHL N/A
- DSS N/A
- 52 Week Low
- RDHL $2.40
- DSS $0.77
- 52 Week High
- RDHL $20.28
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- RDHL 26.68
- DSS 51.43
- Support Level
- RDHL $2.64
- DSS $0.78
- Resistance Level
- RDHL $2.90
- DSS $1.03
- Average True Range (ATR)
- RDHL 0.23
- DSS 0.11
- MACD
- RDHL 0.07
- DSS -0.00
- Stochastic Oscillator
- RDHL 6.76
- DSS 46.16
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.